WASHINGTON - Biotechnology company Moderna Inc. said Monday that its experimental vaccine was 94.5 percent effective in preventing COVID-19, making it the second U.S. firm to show promising results in developing a vaccine against the coronavirus pandemic.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
